or
forgot password
  • cancer clinical trials in saginaw, MI

  • S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Colorectal Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lymphoma
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Prostate Cancer
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Cancer
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Arthralgia, Breast Cancer, Pain
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Lymphoma, Neurotoxicity, Therapy-related Toxicity
    Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer, Cancer Survivor, Hot Flashes
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 54063
    Saginaw, Michigan 48604
    Heavy Uterine Bleeding, Uterine Fibroids
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    St. Mary's of Michigan Medical Center/Field Neurosciences Institute
    Saginaw, Michigan 48604
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Colorectal Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Seton Cancer Institute at Saint Mary's - Saginaw
    Saginaw, Michigan 48601
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Saint Mary's of Michigan
    Saginaw, Michigan 48601
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Lung Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Metastatic Cancer
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Breast Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    St. Mary's Medical Center

    Trial Locations
    St. Mary's Medical Center
    Balcueva Clinic
    Colorectal Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Diarrhea, Radiation Enteritis
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Saint Mary's Seton Cancer Institute
    Saginaw, Michigan 48601
    Breast Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Head and Neck Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Seton Cancer Institute - Saginaw
    Saginaw, Michigan 48601
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Radiation Toxicity
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    St. Mary's Medical Center
    Saginaw, Michigan 48601
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy